Elsevier

Journal of Infection

Volume 41, Issue 2, September 2000, Pages 162-166
Journal of Infection

Regular Article
Species-specific Prevalence of Vaginal Candidiasis Among Patients with Diabetes Mellitus and its Relation to their Glycaemic Status

https://doi.org/10.1053/jinf.2000.0723Get rights and content

Abstract

Objectives: Non- C. albicans Candida species are increasingly being recognized as the cause of vulvo-vaginal candidiasis. These species are often less susceptible to antifungal agents. Patients with diabetes mellitus are at risk for vulvo-vaginal candidasis. We assessed the species-specific prevalence rate and risk of candidiasis in patients with diabetes mellitus and healthy controls.

Methods: Genital tract examination, direct microscopy and fungal cultures of discharge collected by high vaginal swab were undertaken among 78 consecutive patients with diabetes mellitus (mean (±sd) age 32±12 years and body mass index (BMI) 22.3±5.5kg/m2) and 88 age- and BMI-matched healthy females. Glycaemic control in the diabetic cohort was assessed by measuring total glycosylated haemoglobin.

Results: Candida species were isolated in 36 of 78 (46%) subjects with diabetes mellitus and in 21 of 88 (23%) healthy subjects (Chi-squared 9.11, P=0.0025). The predominant Candida species isolated in diabetics with vulvo-vaginal candidiasis were Candida glabrata (39%), C. albicans (26%) and C. tropicalis (17%). In contrast, in the control group, C. albicans, C. glabrata and C. hemulonii comprised 30% each, with none having C. tropicalis infection (for C. tropicalis: diabetic vs. control; 17% vs. nil, P=0.05). Among the diabetic group, subjects with vulvo-vaginal candidiasis had significantly higher mean HbA1 when compared to those who had no such infection (12.8±2.6% vs. 9.7±1.7% respectively, P=0.001). The overall accuracy of direct microscopy and clinical examination for predicting vulvo-vaginal candidiasis was only 77% and 51%, respectively, in the diabetic group, and 83% and 65% in the control group.

Conclusions: Patients with diabetes mellitus had a high prevalence rate (46%) of vulvo-vaginal candidiasis with relative risk of 2.45. The non- C. albicans species such as C. glabrata and C. tropicalis were the predominant species isolated among them. There seems to be a significant link between hyperglycaemia and vulvo-vaginal candidiasis.

References (30)

  • FC Odds

    Resistance of yeast to azole-derivative antifungals

    J Antimicrob Chemother

    (1993)
  • V Redondo-lopez et al.

    Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents

    Obstet Gynecol

    (1990)
  • NJV Bohannon

    Treatment of vulvovaginal candidiasis in patients with diabetes

    Diabetes Care

    (1998)
  • KGMM Alberti et al.

    Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation

    Diabet Med

    (1998)
  • Ajello, L, George, LK, Kaplan, W, Kaufman, L, CDC Laboratory Manual for Medical Mycology, Atlanta, Georgia, CDC, 1963,...
  • Cited by (109)

    View all citing articles on Scopus

    Please address all correspondence to: U. Banerjee, Additional Professor, Chief Laboratories for Clinical Mycology & Investigations of Infections in Immunocompromised Patients, Department of Microbiology, All India Institute of Medical Sciences, New Delhi 110029, India. Fax: 91-11-6862663. E-mail:[email protected]

    View full text